AI-assisted tool for removing early-stage digestive cancers
Part of Cancer, Digestive system clinical trials.
This study tests an AI system that helps doctors remove early-stage cancers or pre-cancers from the esophagus, stomach, or colon more precisely. It may help ensure complete removal while protecting healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have early-stage cancer or high-grade precancerous changes in the esophagus, stomach, or colon
- You are scheduled to have the lesion removed by endoscopic submucosal dissection (ESD)
- You have not had any prior treatment for this lesion
- Your blood clotting is normal (platelets and INR) and you have stopped blood thinners like aspirin or clopidogrel for at least 5 days
- You are in good overall health (American Society of Anesthesiologists grade I or II)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an AI system to help guide doctors during a minimally invasive procedure to remove early-stage lesions in the esophagus, stomach, or colon. If you're scheduled for this surgery, the AI may help make it safer and more precise.
This trial tests whether a real-time artificial intelligence (AI) tool can help doctors find and stop bleeding faster during a type of endoscopic surgery called ESD. It is for people who need this procedure for lesions in the esophagus, stomach, or colon.
This trial tests if artificial intelligence can help doctors more accurately determine how deep early esophageal cancer goes during an endoscopic ultrasound. It may lead to better treatment decisions for people with early signs of esophageal cancer.
This study tests a new way to perform ESD, a minimally invasive procedure to remove early-stage cancers or polyps from the digestive tract. The goal is to see if this new method is safer and more effective than the standard approach.
This study tests an artificial intelligence tool that analyzes images taken during stomach endoscopy to help diagnose early-stage stomach cancer or precancerous changes. The goal is to improve how doctors identify and treat these lesions early, when treatment is most effective.
This study tests a new robot-assisted tool to remove early-stage stomach cancer or precancerous cells through a scope (endoscope) without open surgery. The goal is to see if it is safe and effective at removing the abnormal tissue completely.
Hear when a new Esophageal Squamous Cell Carcinoma (ESCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.